Search Results - de Lope, C.R.

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Complete Response under Sorafenib Treatment for Hepatocellular Carcinoma is Associated to Development of Dermatology Adverse Events

    Complete Response under Sorafenib Treatment for Hepatocellular Carcinoma is Associated to Development of Dermatology Adverse Events by Díaz-González, Á, Rimola, J, María, R, Darnell, A, Varela, M, Pons, F, Hernández-Guerra, M, Delgado, M, Castroagudín, J.F, Matilla, A, Sangro, B, de Lope, C.R, Margarita, S, González, C, Huertas, C, Minguez, B, Ayuso, C, Bruix, J

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    PS-022 - Efficacy and safety of REGORAFENIB in real life in the treatment of hepatocellular carcinoma. Multicenter experience

    PS-022 - Efficacy and safety of REGORAFENIB in real life in the treatment of hepatocellular carcinoma. Multicenter experience by Fraile, M., Ferrer, M.T., Matilla, A.M., Lledó, J.L., Minguez, B., Hernandez, A., Perelló, C., Fernández-Castroagudín, J., de Lope, C.R., Aguilar, M.D.E., Montoliu, S., Sala, M., Romero-Gutiérrez, M., Pascual, S., Urquijo, J.J., Arraez, D.E.M., Rodriguez, M.J.B., Varela, M.

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Efficacy and safety of REGORAFENIB in real life in the treatment of hepatocellular carcinoma. Multicenter experience

    Efficacy and safety of REGORAFENIB in real life in the treatment of hepatocellular carcinoma. Multicenter experience by Fraile, M., Ferrer, M.T., Matilla, A.M., Lledó, J.L., Minguez, B., Hernandez, A., Perelló, C., Fernández-Castroagudín, J., de Lope, C.R., Aguilar, M.D.E., Montoliu, S., Sala, M., Romero-Gutiérrez, M., Pascual, S., Urquijo, J.J., Arraez, D.E.M., Rodriguez, M.J.B., Varela, M.

    Published in Journal of hepatology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Increased risk of liver cancer in cirrhotic patients associated to direct acting antivirals

    Increased risk of liver cancer in cirrhotic patients associated to direct acting antivirals by Reig, M., Mariño, Z., Darnell, A., Lens, S., Sapena, V., Díaz, A., Belmonte, E., Perelló, C., Panero, J.L.C., de Lope, C.R., Llerena, S., Torras, X., Moya, A.G., Sala, M., Morillas, R., Minguez, B., Llaneras, J., Coll, S., Carrión, J.A., Iñarrairaegui, M., Sangro, B., Vilana, R., Sole, M., Ayuso, C., Ríos, J., Forns, X., Bruix, J.

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    LBP-024 - Increased risk of liver cancer in cirrhotic patients associated to direct acting antivirals

    LBP-024 - Increased risk of liver cancer in cirrhotic patients associated to direct acting antivirals by Reig, M., Mariño, Z., Darnell, A., Lens, S., Sapena, V., Díaz, A., Belmonte, E., Perelló, C., Panero, J.L.C., de Lope, C.R., Llerena, S., Torras, X., Moya, A.G., Sala, M., Morillas, R., Minguez, B., Llaneras, J., Coll, S., Carrión, J.A., Iñarrairaegui, M., Sangro, B., Vilana, R., Sole, M., Ayuso, C., Ríos, J., Forns, X., Bruix, J.

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    THU-038 - Complete Response under Sorafenib Treatment for Hepatocellular Carcinoma is Associated to Development of Dermatology Adverse Events

    THU-038 - Complete Response under Sorafenib Treatment for Hepatocellular Carcinoma is Associated to Development of Dermatology Adverse Events by Díaz-González, Á., Rimola, J., María, R., Darnell, A., Varela, M., Pons, F., Hernández-Guerra, M., Delgado, M., Castroagudín, J.F., Matilla, A., Sangro, B., de Lope, C.R., Margarita, S., González, C., Huertas, C., Minguez, B., Ayuso, C., Bruix, J.

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: